2934.99.01.00 - Mycophenolate mofetil

HTS Code 2934.99.01.00 specifically covers Mycophenolate mofetil. This compound is a prodrug of mycophenolic acid, a potent, selective, non-competitive, and reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH). It is primarily used as an immunosuppressant, notably in organ transplantation to prevent rejection, and in the treatment of autoimmune diseases. The classification within Section VI and Chapter 29 signifies its status as an organic chemical, specifically a heterocyclic compound.

This classification distinguishes Mycophenolate mofetil from its sibling categories by its distinct chemical structure and singular, well-defined application as an immunosuppressant. While sibling categories under 2934.99.00 encompass a broader range of "other" heterocyclic compounds, including thiophenes, oxadiazoles, benzoxazoles, and various other complex organic molecules, this specific code is reserved for a single pharmaceutical active ingredient. The other siblings list multiple chemical entities or specific compounds with different functional groups and intended uses, making them distinct from the dedicated classification of Mycophenolate mofetil.

As a leaf node, HTS Code 2934.99.01.00 does not have further subcategories. This means that any import or export of Mycophenolate mofetil, whether in bulk form or as a component of a pharmaceutical product (though finished pharmaceuticals typically fall under Chapter 30), will be classified under this precise code. The specificity ensures accurate duty assessment and statistical tracking for this particular important pharmaceutical compound.